-
Creative Enzymes Has Broadened Its Product list to Accelerate Enzymes-related Projects
Sep 4, 2019, 05:55 AM by Michael CroftSHIRLEY, NY, US - Sep 4, 2019 - As an excellent supplier and manufacturer, Creative Enzymes announced that they have broadened their enzyme product list in order to fully accelerate enzymes related projectsFull story -
Life Image Announces Launch of Real World Imaging™ (RWI™) to Improve Effectiveness of Real World Evidence Programs for Life Sciences and Artificial Intelligence-Led Innovation
Sep 3, 2019, 14:18 PM by Michael CroftNEWTON, MA - Sep 3, 2019 - Life Image, the worlds largest medical evidence network for clinical and imaging data, today announced the launch of its new Real World Imaging (RWI) offering to respond to researcher needs for maturing insights and accelerating drug development decisionsFull story -
BINDING SITE FEATURES BIOLOGICAL MATERIALS FOR TORCH TESTING APPLICATIONS
Sep 3, 2019, 10:50 AM by Michael CroftSAN DIEGO, CA - Sep 3, 2019 - As a leading manufacturer and supplier of products and services to both IVD manufacturers and researchers within the clinical, biopharmaceutical, and life sciences markets, BINDING SITE'sIMMUNOLOGICALS GROUP fully understands the necessity of sourcing high-quality biological materials for your various applicationsFull story -
Bora secures FDA approval for CDMO services
Sep 3, 2019, 08:32 AM by Michael CroftZHUNAN, TAIWAN - Sep 3, 2019 - Bora, a contract development and manufacturing organization (CDMO) that specializes in modified release (MR) and solvent production, has reported a successful FDA general inspection for its facility in Zhunan, TaiwanFull story -
Q-State, LUCA Biologics, AskBio, And More: News From August 2019
Aug 29, 2019, 10:45 AM by Michael CroftFull storyBio-IT World | August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Q-State, LUCA Biologics, AskBio, and more.
-
IDBS achieves SOC 2 compliance
Aug 29, 2019, 04:40 AM by Michael CroftLONDON, UNITED KINGDOM - Aug 29, 2019 - Boston, US and Guildford, UK - 29 August 2019 - IDBS has achieved compliance with SOC 2, following an audit by CyberGuard Compliance, LLC to the American Institute of Certified Public Accountants' (AICPA) Trust Services CriteriaFull story -
Cardiovascular Disease Related Peptides Are Now Accessible at Creative Peptides
Aug 29, 2019, 01:42 AM by Michael CroftNEW YORK, NY - Aug 29, 2019 - Having been dedicated to the great cause of supplying peptides for nearly two decades, the New York-based brand Creative Peptides recently adds another major peptide category for scientists who are involved with cardiovascular disease researchFull story -
Creative Enzymes Upgrades Its Enzymes Products for Research and Industrial Use
Aug 29, 2019, 00:03 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 29, 2019 - Creative Enzymes, a professional enzymes provider located in New York, always hammers at researches and trials in order to provide customers with various enzymes as many as possibleFull story -
BOC Sciences Is Leading Drug Discovery and Process R & D
Aug 28, 2019, 23:35 PM by Michael CroftSHIRLEY, NY - Aug 29, 2019 - Starting from a chemical vendor in 2007, BOC Sciences has now become a well-established brand and is currently leading drug discovery and process R&D, in an attempt to help researchers engaged in this field to find a more efficient and cost-effective approach to early drug developmentFull story -
NIH Announces Genomic Innovator Awards Winners
Aug 28, 2019, 10:55 AM by Michael CroftBio-IT World | The National Human Genome Research Institute announced the winners of their Genomic Innovator Awards. Researchers from the University of Nebraska Medical Center, Omaha; Vanderbilt University Medical Center; Harvard Medical School, Boston; Massachusetts General Hospital, Boston; The City of Hope Comprehensive Cancer Center, Duarte, California; and the University of Maryland-Baltimore were honored.Full story -
HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
Aug 28, 2019, 09:38 AM by Michael CroftCAMBRIDGE,, MA, UNITED STATES - Aug 28, 2019 - HiFiBiO Therapeutics, a pioneer in innovative biotherapeutics with a unique single-cell analytics platform for extensive immune profiling, today announced the completion of a $67 Million Series C financing roundFull story -
Creative Enzymes Has Upgraded Mature Enzyme Services to Accelerate Your Enzymes Discovery Process
Aug 28, 2019, 05:09 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 28, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has upgraded three enzymes related services, including biocatalysis service, enzyme labelling service, and enzyme modification service for researchers to accelerate your enzyme discovery processFull story -
Grant Awarded to MDI Biological Laboratory Scientist James A. Coffman, Ph.D.
Aug 27, 2019, 11:37 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Aug 27, 2019 - The MDI Biological Laboratory has announced that James A. Coffman, Ph.D., has received a two-year grant totaling $166,000 from the National Institutes of Health (NIH) for his research on the regulation of cortisol, a naturally occurring steroid that governs how the body responds to stressFull story -
Baptist Health South Florida Launches New Online Patient Access Experience for Consumers With Technology from Kyruus
Aug 27, 2019, 10:43 AM by Michael CroftBOSTON, MA, UNITED STATES - Aug 27, 2019 - Leading Florida Health System Enhances Digital Capabilities for Both English- and Spanish-Speaking Consumers in the Greater Miami AreaBoston, MA - August 27, 2019 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Baptist Health South Florida, the most-awarded health system in South Florida by UFull story -
Sterling commences large-scale production of Nanologica’s silica particles
Aug 27, 2019, 09:46 AM by Michael Croft, UNITED KINGDOM - Aug 27, 2019 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has started large-scale production of Nanologicas silica particlesFull story -
WCG Introduces Velos eResearch eXpress™
Aug 27, 2019, 08:18 AM by Michael CroftPRINCETON, NJ - Aug 27, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division introduces Velos eResearch eXpress, an out-of-the-box, cloud-based solution that enables clinical research sites to centralize and manage their research activities on a single, automated technology platformFull story -
Microway Provides Vyasa Analytics With NVIDIA DGX-1, NumberSmasher GPU Server
Aug 26, 2019, 15:15 PM by Michael CroftFull storyBio-IT World Brief | Microway announced it has provided an NVIDIA DGX-1 supercomputer and Microway NumberSmasher Tesla GPU Server to Vyasa Analytics.
-
Researchers Beginning To Use CRISPR In Studies
Aug 26, 2019, 15:05 PM by Michael CroftFull storyBio-IT World | After years of discussion, patent lawsuits, and hype, the gene-editing tool know as CRISPR is finally making its way into clinical trials.
-
The Next Trick For CRISPR Is Gene-Editing Pain Away
Aug 23, 2019, 09:35 AM by Michael CroftFull storyMIT Technology Review | A family of street performers could walk on coals. Scientists have paired the discovery with the gene-editing tool CRISPR, in what they say is a step toward a gene therapy that could block severe pain caused by diabetes, cancer, or car accidents without the addictive effects of opioids.
-
Microway Provides Vyasa Analytics NVIDIA® DGX-1™ and NumberSmasher® GPU Server
Aug 21, 2019, 12:22 PM by Michael CroftPLYMOUTH, MA - Aug 21, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has provided an NVIDIA® DGX-1 supercomputer and Microway NumberSmasher® Tesla® GPU Server to deep-learning leader Vyasa AnalyticsFull story